Why Bed Bath & Beyond, Ra Pharmaceuticals, and Freeport-McMoRan Jumped Today
One of these stocks was pushed higher after it revealed who will next sit in the CEO's chair.
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
$47.33
$0.04
0.1%
BATS BZX Real Time Price as of December 11, 2019, 4:00 p.m. EST
View Interactive RARX Charts
Ra Pharmaceuticals, Inc. Common Stock
News & Analysis: Ra Pharmaceuticals, Inc. Common Stock
Why Ra Pharmaceuticals Is Skyrocketing Today
Shares make a triple-digit jump after the company announces that it has agreed to be acquired. Here's what investors need to know.
2 Biotechs Tackling the Challenge of Lou Gehrig’s Disease
Historically, the underlying cause of ALS has evaded researchers, except in rare genetic cases. But more light has been shone on the disease and the potential of new avenues for drug intervention.
Why Nutrisystem, Xperi, and Ra Pharmaceuticals Jumped Today
Find out which of these stocks got a buyout bid.
Here's Why Ra Pharmaceuticals Inc. Is Soaring Today
Investors are cheering for successful results from a mid-stage trial with the company's lead candidate.
Why Ra Pharmaceuticals, Inc. Got Hammered Today
"Positive" phase 2 data for RA101495 SC wasn't positive enough.
Here's Why Ra Pharmaceuticals Inc. Tumbled as Much as 32% Today
Investors find fault in Ra's phase 2 initial data for its lead drug.
